BioCentury
ARTICLE | Clinical News

CCX872: Phase I started

December 10, 2012 8:00 AM UTC

ChemoCentryx began a double-blind, placebo-controlled Phase I trial of single and multiple ascending-doses of oral CCX872 in 40 healthy volunteers. ...